Navigation Links
Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
Date:9/17/2013

mor-specific biomarkers. The coming years will witness commercial opportunities for CTCs in the area of therapeutic selection and patient monitoring.

Fuelled by the need for more effective treatment options and growing focus of the medical community to develop drugs and therapies that target tumor roots, research in the field of Cancer Stem Cells (CSCs) is attracting increased investments. Stem cells also known as progenitor cells, represent cells that are capable of regenerating malignant tumor cells and thus are responsible for the spread of cancer. As a key cause for tumor recurrence, metastasis, and resistance, cancer stem cells are therefore an important theme for R&D, especially as a drug target. The coming years are forecast to witness the development of novel drugs that target cancer stem cells (CSCs).

In addition to technical growth drivers, key market forces fuelling growth include rising awareness about cancer among the patient base, growing disposable incomes and greater healthcare per capita spends especially in developing countries, establishment of latest healthcare facilities and improvement in quality of care offered, and supportive legislations that encourage R&D investments among big pharma companies by mitigating R&D risk exposure in this space.

The study estimates the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) to be a multi-million dollar market, while more precise market-size and growth projections will be made available during the 2nd stage of report preparation, and data analysis.

The research and analyses will be released shortly in the form of a comprehensive research report. The report by design, will attempt to provide exhaustive analysis, data, trends, market share, market size, statistics, forecasts and competitive intelligence. The report is modeled t
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Medicine, recently presented new data on the relationship of genetics and hypertension at ... Congress on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
(Date:8/26/2015)... China Cord Blood Corporation (NYSE: CO ... provider of cord blood collection, laboratory testing, hematopoietic stem ... that the Company has been informed that Magnum Opus ... by Mr. Yuen Kam, chairman of the board of ... (the "Shares") of  Excellent China Healthcare Investment Limited ("KKR ...
Breaking Biology Technology:Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3
... YORK, Nov. 30 The Michael J. Fox Foundation for ... to six research teams working to develop potentially disease-modifying therapies ... Novel Approaches to Drug Discovery for Parkinson,s Disease program, ... ELN ), a neuroscience-based biotechnology company. , The ...
... CHANGCHUN, China and LOS ANGELES, ... Board: CYXN; ,China Yongxin,Pharmaceuticals, or ,the Company,), a leading ... announced it has,completed preparation for distribution of medicines on ... The Chinese government recently formalized the nation,s Essential Drug,List ...
... , BOSTON and COPENHAGEN, Nov. ... today that the Harvard Medical School ICCB-Longwood Screening Facility ... of Excellence. ICCB-L supports investigators at Harvard Medical ... of small molecule and RNAi libraries. , MicroRNAs are ...
Cached Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
(Date:8/5/2015)... Aug. 5, 2015 The biosensors market is ... applications, penetration into newer sectors, and development of devices ... biosensors space has seen the entry of multiple participants ... far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( http://www.frost.com/nee9 ...
(Date:7/31/2015)... de 2015 BGI llevará a cabo la 10ª ... al 25 de octubre de 2015, en ... su décimo aniversario este año. Desde su inauguración en ... reuniones anuales más influyentes del mundo en los campos ... científicas más dinámicas, entusiastas y amenas. ICG-10 ...
(Date:7/31/2015)... , Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... it has filed provisional patent 62/198989 for ... invention highlights a method to advance crypto-currencies such as ... introducing a common, uniform way to manage all payments.  ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... DIEGO , Oct. 25, 2013  Global Payout, Inc. ... Inc. (OTCQB:IWSY) ("IWS"), the leader in cloud based multi-modal ... patented GoCloudID™ Software as a Service (SaaS) platform, which ... run on top of the Fujitsu Cloud IaaS Trusted ...
... In Australia,s Western Desert, Aboriginal hunters use a unique ... hunt, according to a study co-authored by Stanford Woods ... an associate professor of anthropology, and Doug Bird is ... 23 in Proceedings of the Royal Society B ...
... are posing yet another concern of growing importance: ... blooms in freshwater lakes and estuaries around the world, ... water safety. As this nutrient enrichment, or "eutrophication" ... cyanobacteria in harmful algal blooms, scientists said. Researchers ...
Cached Biology News:ImageWare Systems Provides Next Generation Cloud Identity Management and Authentication Services to Global Payout's MoneyTracTM Consolidated Payment Gateway 2ImageWare Systems Provides Next Generation Cloud Identity Management and Authentication Services to Global Payout's MoneyTracTM Consolidated Payment Gateway 3ImageWare Systems Provides Next Generation Cloud Identity Management and Authentication Services to Global Payout's MoneyTracTM Consolidated Payment Gateway 4Aboriginal hunting practice increases animal populations 2Increasing toxicity of algal blooms tied to nutrient enrichment and climate change 2Increasing toxicity of algal blooms tied to nutrient enrichment and climate change 3
... Mass Directed Auto Purification software, a ... system designed for automated compound isolation ... and pharmaceutical discovery programs. The system ... high throughput mass directed auto purification ...
... Anti-M13 polyclonal antibody was derived from ... phage particles.Recombinant protein domains such as antibody ... protein pIII and displayed on phage using ... system utilized in the Ph.D. libraries. Anti-M13 ...
... Ligation Kit enables ligation of ... in just 5 min at ... the DNA concentration, either circular ... (high DNA concentration) ligation products ...
... catalyzes the transfer of the ... 5-terminus of polynucleotides or to ... The enzyme, purified from recombinant ... to phosphorylate RNA, DNA and ...
Biology Products: